Mapping the Bioenergetic Landscape of Oral Cancer Stem Cells: A Systematic Review
Oral Diseases · 2026-10 · 32 (10) · 3089-3100
DOI: 10.1111/odi.70449 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Oral Diseases, online erschienen am 03.08.2026. Verfasst von Rodrigo Elísio de Sá und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Cultura de Células Do Delta (LCCDelta), Universidade Federal Delta do Parnaíba, UFDPar, Parnaíba, PI, Brazil. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Mouth Neoplasms, Mitochondria, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Oral squamous cell carcinoma (OSSC) remains highly lethal, with resistance largely driven by cancer stem cells (CSCs). Mitochondrial reprogramming supports CSC redox control, self‐renewal, and survival. This systematic review aimed to synthesize mitochondrial mechanisms sustaining CSCs in OSCC and evaluate their therapeutic relevance.
Methods
Following PRISMA guidelines and a PROSPERO protocol (CRD420251088208), we searched major databases for studies investigating mitochondrial biogenesis, dynamics, mitophagy, or redox regulation in oral CSCs. Extracted data included molecular pathways, functional roles, and pharmacological targeting.
Results
Ten studies were eligible. Evidence shows that mitochondrial remodeling, through PGC‐1α/ERRα‐mediated biogenesis, DRP1‐dependent fission, BNIP3/PINK1‐regulated mitophagy, and NRF2‐driven antioxidant signaling, supports metabolic flexibility and drug tolerance. These pathways activate stemness regulators, including EGFR/JNK/SOX2, YAP/CCN1, and SIRT1/PGC‐1α, promoting adaptation and recurrence. Pharmacological interventions targeting these nodes, such as DRP1 inhibitors, SIRT1 or ERRα antagonists, and mitophagy‐modulating agents (melatonin, verteporfin), showed potential to sensitize CSCs to conventional therapies.
Conclusion
Mitochondria act as central regulators of CSC biology in OSCC and represent actionable therapeutic targets. Integrating mitochondrial dynamics, metabolism, and redox control provides a framework for overcoming resistance. Further preclinical and clinical studies are needed to translate these vulnerabilities into effective OSCC therapies. Trial Registration PROSPERO, CRD420251088208
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Cultura de Células Do Delta (LCCDelta), Universidade Federal Delta do Parnaíba, UFDPar, Parnaíba, PI, Brazil.
ORCID-Profile: José Delano Barreto Marinho-Filho, Ana Jérsia Araújo
Zitieren
APA
de Sá, R. E., da Rocha, R. B., Alves, B. D. S., de Carvalho, M. E. A., Sousa, J. D. S., Marinho-Filho, J. D. B., & Araújo, A. J. (2026). Mapping the Bioenergetic Landscape of Oral Cancer Stem Cells: A Systematic Review. Oral Diseases, 32(10), 3089-3100. https://doi.org/10.1111/odi.70449
Vancouver
de Sá RE, da Rocha RB, Alves BDS, de Carvalho MEA, Sousa JDS, Marinho-Filho JDB, et al. Mapping the Bioenergetic Landscape of Oral Cancer Stem Cells: A Systematic Review. Oral Diseases. 2026;32(10):3089-3100. doi:10.1111/odi.70449
BibTeX
@article{deS2026,
author = {de Sá, Rodrigo Elísio and da Rocha, Rebeca Barbosa and Alves, Benedito Dos Santos and de Carvalho, Maria Eduarda de Araujo and Sousa, Jayane da Silva and Marinho-Filho, José Delano Barreto and Araújo, Ana Jérsia},
title = {Mapping the Bioenergetic Landscape of Oral Cancer Stem Cells: A Systematic Review},
journal = {Oral Diseases},
year = {2026},
volume = {32},
number = {10},
pages = {3089--3100},
doi = {10.1111/odi.70449}
}
EUVIMED